4
Changes in Ownership
Keros Therapeutics, Inc. Filed Acc 0001221590-26-000005
Director bought 1,000 shares at $11.70 ($11,700)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
BIENAIME JEAN JACQUES · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-04-15 | Purchase : show line 1 in the form 10b5-1 | +1,000 | $11.70 | $11,700 | 8,450 | D |
| Open-market purchases · 1,000 sh · avg $11.70 · $11,700 | ||||||
Loading xslF345X06/form4-04172026_040401.xml…